Prot# HGS1008-C1060: A Phase 3, Randomized, Multi-Center Study to Evaluate the Efficacy & Safety of Albumin Interferon Alfa-2b (alb-IFN) in Combination with Ribavirin Compared with Peginterferon Alfa-2a (PEGASYS or PEG-IFNalfa2a) in Combination with Ribav

Project: Research project

Project Details

StatusFinished
Effective start/end date6/29/076/29/10

Funding

  • Duke University (HGS1008-C1060)
  • Human Genome Sciences, Inc. (HGS1008-C1060)